Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Winchester Bancorp, Inc. reported net income of $1.27 million for the quarter ended September 30, 2026, an increase from $0.96 million in the prior year period. Total assets grew to $1.14 billion, driven by a net increase in loans and interest-bearing deposits, while stockholders' equity slightly decreased due to unrealized losses on available-for-sale securities.
For the quarter ended September 26, 2026, Cirrus Logic reported net sales of $559.5 million and net income of $114.7 million, a slight decrease from the prior year's $131.6 million. The company maintained a strong balance sheet with $720.1 million in cash and cash equivalents while continuing its share repurchase program, spending $160 million on stock buybacks during the first six months of the fiscal year.
Braemar Hotels & Resorts reported third quarter 2026 financial results, highlighted by a 14.4% increase in comparable RevPAR to $284. The company reported a significant net loss of $240.9 million, primarily driven by a $480.0 million termination fee payable to its external advisor recorded during the quarter.
STAAR Surgical reported third quarter 2026 net sales of $83.4 million and net income of $5.6 million. The company achieved record year-to-date revenue of $270.5 million and authorized a new $50 million share repurchase program during the period.
Deluxe reported Q3 2026 financial results with revenue increasing 2.5% to $553.9 million and comparable adjusted revenue growing 9.1%. The company increased its full-year 2026 outlook for revenue and adjusted EBITDA, driven by growth in its Payments and Data segments and the integration of Celero.
Term
Q3 2026
“Our mix shift towards our Payments and Data segments accelerated, driving strong overall enterprise growth during the third quarter. Revenue across our combined Payments and Data businesses expanded by over 21%, as the addition of Celero mid-quarter further accelerated our growth and mix shift progress.”
Barry McCarthy, President and CEO of Deluxe
“Continued expansion of our comparable adjusted EBITDA and year-to-date free cash flow results through the third quarter reflect our focused execution and the ability to expand our margins as revenue scales across our growth segments.”
Chip Zint, Senior Vice President and Chief Financial Officer of Deluxe
Evercore Inc. reported strong growth for the nine months ended September 30, 2026, with net revenues increasing to $3.55 billion from $2.57 billion in the prior year, driven primarily by a significant rise in Advisory Fees. Net income attributable to Evercore Inc. rose to $557.3 million, or $13.49 per diluted share, compared to $388.0 million, or $9.26 per diluted share, in 2025.
Align Technology reported net revenues of $1.01 billion for the third quarter of 2026, a slight increase from $995.7 million in the prior year. Net income for the quarter rose significantly to $135.0 million compared to $56.8 million in Q3 2025, driven by lower costs of revenues and reduced restructuring charges.
TWFG, Inc. reported third quarter 2026 financial results with total revenues increasing 24.6% year-over-year to $79.9 million. The growth was driven by a 25.9% increase in commission income and an 18.5% rise in total written premium, reflecting strong organic and inorganic performance across its agency and MGA platforms.
Term
Q3 2026
“Our third quarter results highlight the strength of TWFG’s diversified platform. Written premium grew 18.5%, total revenues increased 24.6%, and Adjusted EBITDA rose 15.0%, supported by growth across Agency-in-a-Box, Corporate Stores and MGA programs, as well as contributions from recent acquisitions. We continued to grow in a moderating rate environment, demonstrating the value we bring to agents, policyholders and carrier partners.”
Sprout Social reported a decrease in total assets from $523.1 million at the end of 2025 to $493.2 million as of September 30, 2026, primarily driven by a reduction in accounts receivable. The company also reduced its total liabilities from $319.6 million to $286.1 million, including a $7.5 million paydown on its revolving credit facility.
Cosmin Pitigoi, CFO, sold 19,468 shares of Flywire Corp at $20.06 a share, worth $391K in total on Nov 2, 2026. Shares held after the trade: 837,107 (-2.3%).
HMH Holding Inc. reported third quarter 2026 revenue of $171.1 million and net income of $5.0 million. While revenue declined 21% year-over-year due to lower volume across product lines, the company achieved a book-to-bill ratio of 1.12x and expanded its aftermarket platform through the acquisition of Deepwater Riser Services.
Term
Q3 2026
“Equipment order activity remained below our expectations in the third quarter as several larger equipment and upgrade opportunities shifted to later periods. Customer contract awards took longer than anticipated, narrowing execution windows for certain projects, while customers remained disciplined in their capital deployment. Importantly, we have not seen these opportunities disappear and continue to see a healthy pipeline across our installed base. Stronger service activity, favorable business mix, and disciplined cost execution provide resilience as we navigate this near-term variability and position the business for the next phase of market activity.”
Eirik Bergsvik, Chief Executive Officer
“Looking ahead, we are taking deliberate actions to strengthen HMH’s competitive and financial position as these opportunities convert. We are maintaining critical equipment capabilities, investing in long-lead materials to improve delivery readiness and cost positioning, and expanding our aftermarket platform through the acquisition of Deepwater Riser Services. As part of this strategy, we are consolidating our U.S. Gulf riser operations in Houma, Louisiana, creating a more focused and efficient operating footprint while expanding our riser inspection, recertification, refurbishment, and storage capabilities.”
Fox Corp held its Annual Meeting of Stockholders on November 4, 2026, where shareholders elected seven directors to the board, including Lachlan K. Murdoch and Paul D. Ryan. Stockholders also ratified Ernst & Young LLP as the independent auditor and approved executive compensation on an advisory basis, while a stockholder proposal regarding simple majority voting was defeated.
Generac Holdings President, Home Power Gen. Kyle Andrew Raabe Sells $126K of Stock
Kyle Andrew Raabe, President, Home Power Gen., sold 598 shares of Generac Holdings Inc. at $210.00 a share, worth $126K in total on Nov 3, 2026. Shares held after the trade: 9,580 (-2.2%).
Solid Biosciences Inc. reported a significant increase in cash, cash equivalents, and available-for-sale securities, totaling approximately $348.9 million as of September 30, 2026, compared to $187.9 million at year-end 2025. The company's accumulated deficit grew to $1.12 billion, reflecting ongoing losses as it advances its neuromuscular and cardiac clinical candidates.
ARKO Petroleum Corp. reported significant growth in fuel revenue for the nine months ended September 30, 2026, reaching $3.05 billion compared to $2.43 billion in the prior year. The company underwent a capital structure change during the period, transitioning from a net investment by ARKO Parent to a multi-class common stock structure with 12,570,223 Class A and 35,000,000 Class B shares outstanding.
Maravai LifeSciences reported Q3 2026 total revenue of $45.9 million, a 10% increase year-over-year, driven by strong demand for mRNA products and GMP consumables. The company narrowed its net loss to $24.0 million and raised its full-year 2026 revenue and Adjusted EBITDA guidance based on positive momentum in its TriLink and Cygnus segments.
Term
Q3 2026
“Our third- quarter results build on the momentum we established in the first half of the year. TriLink revenue grew 12% year-over-year led by 28% revenue growth for our mRNA products, while Cygnus delivered its sixth consecutive quarter of year-over-year growth, with revenue up 8%.”
Bernd Brust, CEO of Maravai LifeSciences
“Four Discovery mRNA customers transitioned to clinical-stage GMP this quarter, reinforcing our belief that today’s Discovery success will create tomorrow’s GMP opportunity. Based on our third-quarter performance and our expectations for the fourth quarter, we are raising our full-year revenue and adjusted EBITDA guidance.”
Power Integrations reported Q3 2026 revenue of $125.5 million, a 5% sequential increase driven by PowiGaN products and industrial market strength. The company also announced an increase in its quarterly dividend to $0.22 per share starting in 2027 and provided Q4 revenue guidance of $118 million to $126 million.
Term
Q3 2026
“Revenue grew five percent over the prior quarter driven by PowiGaN™ products as well as continued strength in the industrial market, where revenue is up 13 percent year-to-date. We also delivered strong earnings growth in the quarter reflecting our continued focus on expense discipline and profitability. Power is becoming a critical constraint thanks to AI and electrification, calling for dramatic advances in efficiency and power density. Our high-voltage technology and system expertise are well aligned with these challenges, and we are excited about our product roadmap and the opportunities ahead to drive shareholder value.”
Hamilton Beach Brands reported Q3 2026 revenue growth of 5.6% to $140.3 million, driven by a recovery in its U.S. consumer business and strong growth in its Health segment. Operating profit rose 52.6% to $4.4 million as gross margins improved significantly following the mitigation of tariff-related headwinds from the prior year. However, the company lowered its full-year outlook due to cautious holiday inventory commitments from retail partners amid declining consumer sentiment.
Term
Q3 2026
“Our third quarter results were in line with our expectations and reflect the recovery of our U.S. consumer business following last year’s tariff related headwinds, coupled with the margin benefits from our ongoing tariff mitigation actions.”
R. Scott Tidey, President and Chief Executive Officer
“Unfortunately, with consumer sentiment declining over the past couple of months, several of our retail partners have become more cautious with their inventory commitments for the upcoming holiday season. As a result, we now expect fourth-quarter sales to be lower than previously anticipated and have revised our full-year outlook accordingly.”
R. Scott Tidey, President and Chief Executive Officer
Arcutis Biotherapeutics reported Q3 2026 net product revenues of $143.9 million, a 45% year-over-year increase driven by strong demand for its ZORYVE portfolio. The company maintained positive operating cash flow of $18.9 million and raised its full-year 2026 net product sales guidance to a range of $535 million to $545 million.
Term
quarter ended September 30, 2026
“Yet another strong quarter of performance reflects the consistent execution of our corporate strategy and further strengthens our financial position. ZORYVE continues to lead the branded non-steroidal topical segment driven by its efficacy and tolerability across multiple inflammatory skin conditions and patient populations.”
Frank Watanabe, president and chief executive officer
Viper Energy, Inc. filed its Q3 2026 report showing 192,668,368 Class A and 168,551,337 Class B shares outstanding as of October 30, 2026. The company continues to focus on mineral and royalty interests in the Permian Basin, highlighting recent strategic transactions including the Riverbend and McElroy Ranch acquisitions.
For the nine months ended September 30, 2026, Sixth Street Lending Partners reported total investment income of $703.1 million and net investment income of $433.2 million. The company's net asset value per share decreased to $28.13 from $28.51 at the end of 2025, primarily driven by $162.6 million in total net unrealized and realized losses.
CDW Corp reported net sales of $6.75 billion for the third quarter of 2026, a significant increase from $5.74 billion in the prior year period. Net income rose to $309.8 million, supported by strong operating income growth, while the company continued its capital return strategy through $652.7 million in share repurchases during the first nine months of the year.
L.B. Foster Company reported a significant increase in net income for the nine months ended September 30, 2026, reaching $11.4 million compared to $5.0 million in the prior year period. Total net sales grew by 12.7% year-over-year to $427.7 million, driven by strong performance in both goods and services segments.
Strategy Director Jarrod M. Patten Sells $129K of Stock
Jarrod M. Patten, Director, sold 950 shares of Strategy Inc at $136.04 a share, worth $129K in total on Nov 3, 2026. Shares held after the trade: 28,406 (-3.2%).
Credit Acceptance Insider Thomas N. Tryforos Buys $1.46M of Stock
Thomas N. Tryforos bought 3,000 shares of Credit Acceptance Corp at $485.20 a share, worth $1.46M in total on Nov 2, 2026. Shares held after the trade: 3,000.
Blue Owl Credit SLF LLC reported a net increase in members' equity from operations of $31.0 million for the quarter ended September 30, 2026, up from $13.3 million in the prior year period. Total assets grew significantly to $3.56 billion compared to $2.48 billion at year-end 2025, driven by an increase in investments at fair value.
Blue Owl Credit SLF LLC reported total investment income of $49.7 million for the quarter ended September 30, 2026, and a net increase in members' equity from operations of $31.0 million. Total assets grew significantly to $3.56 billion from $2.48 billion at the end of 2025, driven by an increase in investments at fair value.
Xencor reported financial results for the third quarter ended September 30, 2026, highlighting clinical progress for its lead bispecific antibody XmAb819 in renal cell carcinoma. The company ended the quarter with $412.4 million in cash and equivalents, providing a projected runway into 2028.
“Xencor’s lead CD3 T-cell engaging bispecific antibody, XmAb819, has demonstrated compelling clinical data in advanced clear cell renal cell carcinoma, and our plans for moving XmAb819 into earlier lines of treatment as a monotherapy and in combination with anti-PD(L)1 are underway, with evaluation of XmAb819 in additional ENPP3-positive tumor types also ongoing.”
Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor
Cirrus Logic reported Q2 FY2027 revenue of $559.5 million and GAAP EPS of $2.23, driven by strong demand for smartphone components. The company also announced that its Board of Directors authorized an additional $500 million for its stock repurchase program.
“Cirrus Logic delivered solid results in the September quarter primarily driven by strong demand and increased content shipping into smartphones. During the quarter we were pleased to see our custom components featured in newly launched smartphones, in addition to broader adoption of our third-generation camera controller in these devices.”
John Forsyth, Cirrus Logic president and chief executive officer
“We also made progress on new product development as we began sampling our analog front-end components for smart metering and taped out both our fourth-generation camera controller for smartphones and second-generation smart codec for AI-enabled PCs. With an extensive roadmap and strong pipeline of opportunities, we remain confident in our ability to grow long-term shareholder value.”
John Forsyth, Cirrus Logic president and chief executive officer
Apollo IG Core Replacement, L.P. issued unregistered limited partnership interests for aggregate cash consideration of approximately $478.8 million on November 1, 2026. The sale was conducted as part of the company's continuous private offering. Additionally, the company reported a Net Asset Value (NAV) of $1,295.5 million as of September 30, 2026.